Rina Rubinstein

SPECT/CT hybrid imaging with 111In-pentetreotide in assessment of neuroendocrine tumours.

objective  Somatostatin receptor scintigraphy (SRS) of neuroendocrine (NE) tumours is often challenging because of minute lesion size and poor anatomic delineation. This study evaluates the impact of sequentially performed single‐photon emission computed tomography (SPECT)/CT fusion on SRS study interpretation and clinical management of these tumours.

68Ga-DOTA-NOC PET/CT Imaging of Neuroendocrine Tumors: Comparison with 111In-DTPA-Octreotide (OctreoScan®)

PurposeRecent data have indicated that 68Ga-DOTA-NOC positron emission tomography/X-ray computed tomography (PET/CT) may yield improved images in a shorter acquisition protocol than 111In-DTPA-octreotide (OctreoScan®, OCT). Therefore, we performed a prospective comparison of 68Ga-DOTA-NOC and OCT for the detection of neuroendocrine tumors (NETs).MethodsNineteen patients (eight carcinoid, nine pancreatic NETs, and two NE carcinoma of unknown origin) with previous positive OCT scans underwent 68Ga-DOTA-NOC PET/CT and OCT single-photon emission computed tomography imaging for staging or follow-up. Findings were compared by region and verified with conventional imaging.ResultsAll images of both modalities demonstrated focal uptake, often at multiple sites. 68Ga-DOTA-NOC images were clearer than OCT images, facilitating interpretation. Similar foci were identified with both modalities in 41 regions, with additional foci on 68Ga-DOTA-NOC in 21 and on OCT in 15 regions. CT, magnetic resonance imaging, or ultrasound confirmed the concordant findings in 31 of 41 regions and findings seen with 68Ga-DOTA-NOC only in 15 of 21 regions. Findings seen with OCT only were less clear and were only confirmed in 4 of 15 regions. 68Ga-DOTA-NOC had impact on staging in four patients and on management in three patients.ConclusionsAlthough 68Ga-DOTA-NOC and OCT images were similar, in this study, 68Ga-DOTA-NOC demonstrated more true positive tumor foci and was better tolerated by patients. This direct comparison supports replacement of OCT with 68Ga-DOTA-NOC-PET/CT in the evaluation of NETs.

Ga-68 DOTA-NOC uptake in the pancreas: pathological and physiological patterns.

Objective: Gallium-68 (Ga-68) DOTA-1-NaI3-octreotide (DOTA-NOC) positron emission tomography (PET)/computed tomography (CT) is increasingly used for neuroendocrine tumors (NETs), often found primarily in the pancreas. However, physiologic uptake of DOTA-NOC has been described in the uncinate process of the pancreas. We studied DOTA-NOC uptake in this organ. Materials and Methods: Ninety-six patients underwent 103 DOTA-NOC scans, with pathology-proven pancreatic NET (n = 40) and nonpancreatic NET or biochemical suspicion of NET (n = 63). Results: DOTA-NOC uptake was detected in 35 documented pancreatic tumor sites (SUV: 5.5–165; mean: 25.7 ± 28.8; median: 17.8). Among 63 cases without previous known pathology, uptake was suspicious for tumor in 24 sites (SUV: 4.7–35; mean 16.3 ± 8.0; median: 14.1), and in 38 sites, it was judged as physiological, generally lower relative to adjacent structures (SUV: 2.2–12.6; mean: 6.6 ± 2.2; median: 6.2). In 24 scans with suspected tumor and in 37 of 38 scans with physiological uptake, diagnostic computed tomography or magnetic resonance imaging or endoscopic ultrasonography failed to detect tumor. Conclusions: Pancreatic DOTA-NOC uptake must be interpreted with caution, and further studies are required.

Positron emission tomography in interstitial lung disease.

Background and objectives:  A high rate of glycolysis may reflect the inflammatory activity of interstitial lung disease (ILD). This prospective study investigated whether PET can distinguish IPF, a primarily fibrotic process, from other entities of ILD that have a marked inflammatory component.

USE OF 201THALLIUM BRAIN SPECT, IMAGE REGISTRATION, AND SEMI-QUANTITATIVE ANALYSIS IN THE FOLLOW-UP OF BRAIN TUMORS

OBJECTIVE To assess the use of 201Thallium SPECT and of Thallium (Tl) uptake indices in the detection and follow-up of cerebral tumors. MATERIAL AND METHODS Two-hundred eighty 201Tl, 135 99mTc-HMPAO scintigraphies and 280 MRI studies were acquired in 135 patients with cerebral tumors. Three types of Tl uptake indices were calculated by establishing the ratio of the lesion activity to an homologous ROI (I1), the contralateral hemisphere (I2), and the contralateral scalp (I3). Intermodal coregistration between Tl-SPECT and MRI when used, was performed using Pietrzyk visual interactive method. RESULTS Tl uptake indices showed mean values of 2.0 +/- 0.5 (I1); 1.77 +/- 0.57 (I2) and 1.11 +/- 0.40 (I3) in positive scans, and of 1.05 +/- 0.22 (I1), 0.88 +/- 0.22 (I2) and 0.50 +/- 0.15 (I3) in negative scans, respectively. A linear combination of the two less correlated indices lead to a more powerful discrimination between positive and negative studies. Longitudinal follow-up studies in the same patients showed good concordance between the index values and the course of the disease. CONCLUSION The use of Tl uptake indices improves the accuracy of Tl-SPECT in the follow-up of brain tumors.

A case of metastatic adamantinoma responding to treatment with pazopanib.

Collins BT , Erickson K , Reichner CA , Collins SP , Gagnon [9] GJ , Dieterich S , et al . Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors . Radiat Oncol 2007 ; 2 : 39 . Collins BT , Vahdat S , Erickson K , Collins SP , Suy S , Yu X , [10] et al . Radical cyberknife radiosurgery with tumor tracking: An effective treatment for inoperable small peripheral stage I non-small cell lung cancer . J Hematol Oncol 2009 ; 2 : 1 . Bhagat N , Fidelman N , Durack JC , Collins J , Gordon RL , [11] LaBerge JM , et al . Complications associated with the percutaneous insertion of fi ducial markers in the thorax . Cardiovasc Intervent Radiol 2010 ; 33 : 1186 – 91 . Kupelian PA , Forbes A , Willoughby TR , Wallace K , Manon [12] RR , Meeks SL , et al . Implantation and stability of metallic fi ducials within pulmonary lesions . Int J Radiat Oncol Biol Phys 2007 ; 69 : 777 – 85 . Korreman SS , Juhler-Nottrup T , Fredberg PG , Navrsted PA , [13] Enmark M , Nystrom H , et al . The role of image guidance in respiratory gated radiotherapy . Acta Oncol 2008 ; 47 : 1390 – 6 .

Diagnostic Computed Tomography Coregistration With In-111-dtpa-octreotide Single Photon Emission Tomography/low-dose Computed Tomography.

Objectives In-111-DTPA-octreotide (OctreoScan) is still pivotal for neuroendocrine tumor imaging, despite the introduction of Ga-68-octreotide tracers. Low-dose computed tomography (LDCT) assists in the localization of SPECT findings but often results in uncertain interpretation. This retrospective study evaluates the impact of coregistration of In-111-DTPA-octreotide SPECT/LDCT with diagnostic CT on interpretation. Methods Thirty-five consecutive studies, in which coregistration was performed because of uncertain interpretation, were evaluated. Presence of somatostatin receptors was categorized retrospectively as definitely positive, probably positive, probably negative, or definitely negative with and without rigid registration with diagnostic CT, and possible added value of coregistration was evaluated. Results Coregistration was performed in 35 studies. However, on subsequent reading, 4 SPECT/CTs yielded definite results and were omitted. Coregistration was helpful in 30 of the remaining 31 cases, changing reading to definitely positive (7) or to definitely negative (23). In 13 of the 23 cases, diagnosis changed from probably positive to definitely negative. Coregistration contributed in 42 of 48 sites, with greatest benefit in the liver (13/14), pancreas (10/10), and lymph nodes (6/6). Conclusions Coregistration is becoming increasingly easier and may be utilized when SPECT/LDCT is inconclusive.